Ronald Blue Trust, Inc. Pds Biotechnology Corp Call Options Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
61Shares Held
4.26MCall Options Held
163KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$759,6680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$650,8580.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$385,2840.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$343,5350.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $44.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...